Lynx Financial 德石资本

Lynx Financial is a healthcare and life science -focused fund, investing in innovative technologies for the benefits of patients around the world. We are a group of physicians, scientists, entrepreneurs, consultants and investment professionals that share a common goal of advancing sciences and medicine, as well as achieving commercial success and economic returns.

KUOPIO, Finland, Aug. 20, 2024 /PRNewswire/ -- Bone Index Finland Ltd, a pioneering company in medical technology, proudly announces the completion of its latest financing round and a strategic partnership with Lynx Financial (HK) Limited. This partnership aims to enhance Bone Index's distribution and service capabilities in North America and Asia Pacific.

Basel, Switzerland / Kuopio, Finland – March 30th 2023. Aurealis Therapeutics, a synthetic biology company developing ground-breaking cell and gene therapies for high unmet medical needs, has raised over $10 million through a Series A financing round co-led by Lynx Financial and TESI (Finnish Industry Investment Ltd) with participation of Huahai Pharmaceuticals, family offices and biotech HNWIs.

Edinburgh, Mar 8, 2023 -- Calcivis, dental imaging technology company, is setting its sights on US growth having secured pre-market approval (PMA) from the US Food and Drug Administration (FDA). As the first Scottish medical device to secure the coveted accreditation, the Calcivis Imaging System aims to revolutionise the dental sector by enabling the move to a more preventive treatment model.